Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Thiamine vs. Placebo to Increase Oxygen Consumption After Cardiac Arrest

Phase 2

Terminated

Conditions: Lactic Acidosis
Thiamin Deficiency
Cardiac Arrest
Shock

Interventions: Drug: Thiamine
Other: placebo

First Posted Date: 2016-11-28

Last Posted Date: 2025-04-10

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 41

Registration Number: NCT02974257

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Fibrinolysis Compared to Thoracoscopy for Pleural Infection

Not Applicable

Completed

Conditions: Pleural Diseases
Pleural Infection

Interventions: Other: Medical Thoracoscopy
Other: Fibrinolytic Group

First Posted Date: 2016-11-25

Last Posted Date: 2019-12-26

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 32

Registration Number: NCT02973139

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Saxenda: Underlying Mechanisms and Clinical Outcomes

Phase 4

Active, not recruiting

Conditions: Obesity

Interventions: Drug: liraglutide
Other: Placebo

First Posted Date: 2016-10-26

Last Posted Date: 2025-03-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 28

Registration Number: NCT02944500

Locations: 🇺🇸
Beth Israel Deaconess Medical Center General Clinical Research Center, Boston, Massachusetts, United States

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

Phase 2

Completed

Conditions: Cardiac Arrest

Interventions: Dietary Supplement: Ensure
Drug: Ubiquinol

First Posted Date: 2016-10-17

Last Posted Date: 2021-02-15

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 48

Registration Number: NCT02934555

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Procedure: standard lumpectomy without nonlinear microscopy imaging
Device: nonlinear microscopy imaging of excised surgical margins

First Posted Date: 2016-10-06

Last Posted Date: 2024-05-09

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 98

Registration Number: NCT02926729

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Anesthetics to Prevent Lung Injury in Cardiac Surgery

Phase 1

Completed

Conditions: Inflammatory Lung Injury
Ischemia-Reperfusion Lung Injury
Postoperative Pulmonary Complications

Interventions: Drug: Sevoflurane
Drug: Propofol

First Posted Date: 2016-09-29

Last Posted Date: 2021-05-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 51

Registration Number: NCT02918877

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Phase 2

Terminated

Conditions: Diabetes Complications
Diabetes Mellitus
Diabetic Neuropathies

Interventions: Drug: IGIV-C
Drug: 0.9% Sodium Chloride

First Posted Date: 2016-09-27

Last Posted Date: 2024-05-07

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 13

Registration Number: NCT02915263

Locations: 🇺🇸
Beth Israel Deaconness Medical Center, Boston, Massachusetts, United States

Prevention of Early Postoperative Decline

Not Applicable

Completed

Conditions: Postoperative Cognitive Dysfunction
Delirium

Interventions: Device: Lumosity

First Posted Date: 2016-09-21

Last Posted Date: 2020-06-16

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 45

Registration Number: NCT02908464

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

FGF21 and Fructose Challenge in Humans

Not Applicable

Completed

Conditions: Fasting

Interventions: Dietary Supplement: oral carbohydrate challenge

First Posted Date: 2016-08-31

Last Posted Date: 2023-08-14

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 50

Registration Number: NCT02884791

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS

Phase 1

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Procedure: fecal microbiota transplantation
Drug: placebo fecal microbiota transplantation
Procedure: FMT with antibiotic pre-treatment (v1)
Procedure: FMT with antibiotic pre-treatment (v2)

First Posted Date: 2016-07-28

Last Posted Date: 2019-12-23

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 80

Registration Number: NCT02847481

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy